A Phase II Clinical Study of HLX22 in Combination With Trastuzumab and Chemotherapy
A Phase II Clinical Study of HLX22 in Combination With Trastuzumab and Chemotherapy
Active, not recruiting · NCT07176702 · Registry updated 2025-12-05Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| A Phase II Clinical Study of HLX22 in Combination With Trastuzumab and Chemotherapy | microphthalmia, syndromic 9 | Active, not recruiting | Phase 2 | 2025-12-05 | NCT07176702 |
2 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Shanghai Zhongshan Hospital | 347 |
| The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School | 164 |
2 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Nanjing Drum Tower Hospital | Nanjing | China | 2 |
| Zhongshan Hospital, Fudan University | Shanghai | China | 1 |